13FPulse
中
BE

BEAM BEAM THERAPEUTICS INC

2026Q2 · CUSIP 07373V105 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
272
Institutions that reported holding it to the SEC
Net increase in holders
+23
Last quarter 249 → now 272
How unusual is that
Top 20%
Stronger buying than 85% of US stocks
What the filings say, in one paragraph

272 funds held BEAM at the end of 2026Q2, up 23 from the quarter before. That is stronger buying than 85.4% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $156M(YoY +158.9%), return on equity is -8.1%. BEAM has had 8 buying rushes in its history, and the price moved +10.0% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2020Q2: holders=69 2020Q3: holders=83 2020Q4: holders=156 2021Q1: holders=206 2021Q2: holders=228 2021Q3: holders=229 2021Q4: holders=230 2022Q1: holders=235 2022Q2: holders=203 2022Q3: holders=222 2022Q4: holders=209 2023Q1: holders=204 2023Q2: holders=191 2023Q3: holders=193 2023Q4: holders=185 2024Q1: holders=218 2024Q2: holders=213 2024Q3: holders=218 2024Q4: holders=233 2025Q1: holders=237 2025Q2: holders=216 2025Q3: holders=217 2025Q4: holders=246 2026Q1: holders=249 2026Q2: holders=272 -73 -36.5 +0 +36.5 +73 62174286 20Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 8 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20% — —
2025Q4 Top 20% -2.8% —
2024Q1 Top 10% +1.5% -2.3%
2022Q3 Top 10% -9.7% -27.7%
2021Q2 Top 20% -11.3% -27.5%
2021Q1 Top 5% +43.8% +27.6%
2020Q4 Top 10% -31.7% -1.7%
2020Q3 Top 20% +191.9% +92.0%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
140
Change in large funds
+23
Total value they hold
$4.1B
Funds buying for the first time
62
Funds that sold out entirely
39
Price change that quarter
+9.3%
Funds holding puts (bearish)
3
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.67
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+158.9%
Net margin
-55.5%
ROE
-8.1%
Debt ratio
23.0%
FCF (TTM)
-$373M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.42 2021-12-31: EPS -0.77 2022-03-31: EPS -1.01 2022-06-30: EPS -1.02 2022-09-30: EPS -1.56 2022-12-31: EPS -0.54 2023-03-31: EPS -1.33 2023-06-30: EPS -1.08 2023-09-30: EPS -1.22 2023-12-31: EPS 1.91 2024-03-31: EPS -1.21 2024-06-30: EPS -1.11 2024-09-30: EPS -1.17 2024-12-31: EPS -1.09 2025-03-31: EPS -1.23 2025-06-30: EPS -1.00 2025-09-30: EPS -1.10 2025-12-31: EPS 2.52 2026-03-31: EPS -0.91 2026-06-30: EPS -1.18 0M 158M 316M $M -1.72 0.53 2.77 2019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-131M40M211M 20192020202120222023202420252026
Latest quarter $-131M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.